Form 4 for ICU SeaStar Medical Holding Corp

Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-28 · accession 0000899243-22-034704 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-11-01	2022-10-28	ICU	Union Carbide Employees' Pension Plan Trust	10%	A - Grant	—	+2.77M	2.77M	New	—
D	2022-11-01	2022-10-28	ICU	Union Carbide Employees' Pension Plan Trust	10%	P - Purchase	—	+200.0K	2.97M	+7%	—
D	2022-11-01	2022-10-28	ICU	Union Carbide Employees' Pension Plan Trust	10%	P - Purchase	—	+200.0K	200.0K	New	—
D	2022-11-01	2022-10-28	ICU	Union Carbide Employees' Pension Plan Trust	10%	A - Grant	—	+1,151	1,151	New	—

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-10-28	A	A	2,766,555	—	2,766,555	D	—	—	(F1) On October 28, 2022, LMF Acquisition Opportunities, Inc., a Delaware corporation ("LMF"), consummated a business combination (the "Business Combination") by and among LMF, LMF Merger Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of LMF ("Merger Sub") and SeaStar Medical, Inc., a Delaware corporation ("SeaStar Medical"), pursuant to which SeaStar Medical merged with and into Merger Sub, with SeaStar Medical continuing as the surviving entity in the merger as a wholly-owned subsidiary of LMF, and with LMF changing its name to SeaStar Medical Holding Corporation ("SeaStar Medical Holdings"). As part of the Business Combination each share of SeaStar Medical stock was exchanged for 1.20321 shares of common stock of SeaStar Medical Holdings ("Common Stock").
2	Common	Common Stock	2022-10-28	P	A	200,000	—	2,966,555	D	—	—	(F2) In a concurrent private placement in connection with the Business Combination, the Reporting Person acquired 200,000 shares of Common Stock and warrants to purchase 200,000 shares of Common Stock for an aggregate purchase price of $2,000,000.
3	Derivative	Warrants (Right to Buy)	2022-10-28	P	A	200,000	—	200,000	D	$11.50 · — to 2027-10-28	200,000 Common Stock	(F2) In a concurrent private placement in connection with the Business Combination, the Reporting Person acquired 200,000 shares of Common Stock and warrants to purchase 200,000 shares of Common Stock for an aggregate purchase price of $2,000,000. (F5) The warrants are fully exercisable
4	Derivative	Warrants (Right to Buy)	2022-10-28	A	A	1,151	—	1,151	D	$10.00 · — to 2025-06-20	1,151 Common Stock	(F4) As part of the Business Combination, each SeaStar Medical warrant was exchanged for a warrant to purchase 1.20321 shares of Common Stock. (F3) The warrants are fully exercisable.